Match

L’ATTITUDE Ventures hosts its 2023 Match-Up Competition

Retrieved on: 
Wednesday, October 11, 2023
Match, Consumer, Aerospace Journalist of the Year Awards, Video game

The Match-Up program includes founder showcases, investor thought leadership discussions, capital matchmaking opportunities, and a pitch competition to determine the L'ATTITUDE Latino Startup of the Year.

Key Points: 
  • The Match-Up program includes founder showcases, investor thought leadership discussions, capital matchmaking opportunities, and a pitch competition to determine the L'ATTITUDE Latino Startup of the Year.
  • Leading up to the event, L'ATTITUDE Ventures meticulously reviewed hundreds of submissions and ultimately extended invitations to 19 companies to participate.
  • “We were thrilled to have so many amazing founders present at this year’s Match-Up competition in Miami.
  • L'ATTITUDE Ventures aims to fund and catalyze a much-needed transformation in the narrative surrounding venture capital into the U.S. Latino/a community.

Be The Match Raises $1.1 Million at Annual Gala

Retrieved on: 
Thursday, October 5, 2023
National Marrow Donor Program, WCCO (AM), Ioan, Patient, Love, EPlus, Bone marrow, Leukemia, Science, Research, NMDP, Dentistry, Match

These funds go directly to providing patient assistance grants, pioneering research in the transplant field, and expanding the diversity of the Be The Match Registry®.

Key Points: 
  • These funds go directly to providing patient assistance grants, pioneering research in the transplant field, and expanding the diversity of the Be The Match Registry®.
  • In 2022, Be The Match Foundation provided $6.1 million in grants to 2,320 patients and their families in need of financial assistance.
  • Ever since experiencing the impact of Be The Match, the Furlong Family continues to be steadfast supporters.
  • When you think about what Be The Match stands for - it is the perfect intersection of science and love.

NRMP Establishes Standardized Applicant Placement Rate Metrics for the Main Residency Match® and SOAP®

Retrieved on: 
Wednesday, October 11, 2023
International, Non-U.S. operators of the M60 Patton, Doctor of Health Science, MBA, Student, Applicant (sketch), Acceptance, Match rating approach, MD, NRMP, SOAP, BSN, National Resident Matching Program, Marketing, Health insurance, Phosphorus, Nursing, Match

WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) announced today new reporting for the overall placement rate of participants in the Main Residency Match and the Supplemental Offer and Acceptance Program® (SOAP). The NRMP has released a whitepaper, Applicant Placement Rate in the Main Residency Match and Supplemental Offer and Acceptance Program, which reports for the first time both Match and overall placement data for all applicants compared to those who submitted certified rank order lists of programs in the Match. This new placement data offers unprecedented insights into the transition to residency process.

Key Points: 
  • New whitepaper explores the applicant Match Rate vs. Placement Rates
    WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) announced today new reporting for the overall placement rate of participants in the Main Residency Match and the Supplemental Offer and Acceptance Program® (SOAP).
  • At the conclusion of each Main Residency Match cycle, the NRMP has historically reported the applicant Match Rate.
  • To better understand the overall placement rate of Match participants, the NRMP will conduct an additional 10-year historical analysis of the Match Rate and Placement Rates.
  • By releasing both the Match Rate and Placement Rates, the NRMP has established a standardized calculation and definition of applicant placement data, incorporating the multiple variables associated with Match applicants."

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

Retrieved on: 
Monday, October 9, 2023
Partnership, Senior, Match, Cryopreservation, Business, Cell, Medicine, Collection, Pharmaceutical industry, Fine chemical, EU

MINNEAPOLIS and NASHVILLE, Tenn. , Oct. 9, 2023 /PRNewswire/ -- Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport (NASDAQ: CYRX), a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, today announced a new strategic partnership. The collaboration will expand the capabilities of IntegriCell™, a standardized bioprocessing, cryopreservation and distribution solution for the global cell therapy market.  With cryopreservation facilities in the U.S. and EU, IntegriCell™ is poised to support decentralized and centralized manufacturing models, enabling and accelerating patient access to innovative new therapies. 

Key Points: 
  • The collaboration will expand the capabilities of IntegriCell™, a standardized bioprocessing, cryopreservation and distribution solution for the global cell therapy market.
  • With cryopreservation facilities in the U.S. and EU, IntegriCell™ is poised to support decentralized and centralized manufacturing models, enabling and accelerating patient access to innovative new therapies.
  • This solution will provide cell and gene therapy researchers, developers and manufacturers with consistent starting materials cryopreserved to improve manufacturing slot utilization leading to increased yields bringing new cell and gene therapies to market faster and more affordably.
  • "We are excited to work with Cryoport to continue to set new standards, expand accessibility and accelerate progress in the development of potentially life-saving cell and gene therapies," said Chris McClain, Senior Vice President Sales and Business Development at Be The Match BioTherapies.

GolfLync Surpasses 67,000 Members Nationwide and Hosts Members in Over 700 Private and Public Virtual Golf Clubs™

Retrieved on: 
Tuesday, October 3, 2023
Closed user group, VGC, META, MTCH, Golf, MOMO, PINS, Love, NYSE, Social media, IBN, Pinterest, Match

From local golf clubs to expansive national networks, GolfLync's revolutionary "Virtual Golf Clubs™ (VGC)" have reshaped how golfers engage, share experiences and revel in their shared love for the sport.

Key Points: 
  • From local golf clubs to expansive national networks, GolfLync's revolutionary "Virtual Golf Clubs™ (VGC)" have reshaped how golfers engage, share experiences and revel in their shared love for the sport.
  • Members are wholeheartedly embracing the platform's innovative features, with private and public VGCs acting as epicenters for organizing tee times, sharing golf experiences, hosting events and building enduring golfing connections.
  • The remarkable scale of GolfLync's growth stems from the genuine enthusiasm and interaction of its members.
  • To learn more about GolfLync, explore the official website at www.golflync.com and enjoy a new way to share your golf experiences.

National Marrow Donor Program® (NMDP)/Be The Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access To Transplant

Retrieved on: 
Tuesday, September 26, 2023
Health, National Marrow Donor Program, Partnership, Biobank, Bone marrow, Cell, PBSC, Stem cell, Cryopreservation, Patient, Physician, NMDP, Haematopoietic system, Dentistry, Match

These new collaborations add industry-leading expertise in cryopreservation and storage of hematopoietic stem cells and will increase donor availability.

Key Points: 
  • These new collaborations add industry-leading expertise in cryopreservation and storage of hematopoietic stem cells and will increase donor availability.
  • The NMDP cryopreservation service is available to any transplant center in the NMDP/Be The Match network.
  • This process increases flexibility for the donor and the ability of a patient to secure a cell source.
  • This partnership will build on Comprehensive Cell Solutions’ mission to change lives, one patient at a time.”
    For more information on NMDP cryopreservation service, visit their website .

GVHD Alliance Commemorates Blood Cancer Awareness Month: Welcomes The Leukemia & Lymphoma Society, Announces Meredith A. Cowden Patient Advocacy Achievement Award

Retrieved on: 
Tuesday, September 12, 2023
Graft-versus-host disease, National Marrow Donor Program, Meredith, Education, RYE, Integration, Quality of life, Cell, BMT, LLS, Organization, Cowden, Leukemia & Lymphoma Society, Patient, NMDP, Transplant, Match, Sanofi, Leukemia, Society, Support, Dentistry, Nursing, GVHD

The Alliance is also announcing the inaugural Meredith A. Cowden Patient Advocacy Achievement Award, honoring a member of the GVHD community who is making a profound difference in the lives of GVHD patients.

Key Points: 
  • The Alliance is also announcing the inaugural Meredith A. Cowden Patient Advocacy Achievement Award, honoring a member of the GVHD community who is making a profound difference in the lives of GVHD patients.
  • GVHD is a rare disease that commonly impacts allogeneic blood and marrow transplant recipients, meaning the cells came from a donor.
  • The Meredith A. Cowden Patient Advocacy Achievement Award will be presented on October 13, 2023, during the Meredith A. Cowden Foundation's GVHD Symposium in Independence, Ohio.
  • I am humbled to be recognized in such a meaningful way," said Meredith Cowden of the Meredith A. Cowden Foundation.

NRMP®'s Transition to Residency Conference to be held October 5 - 7, 2023 in Boston

Retrieved on: 
Monday, September 11, 2023
Online, Session (computer science), Partnership, Impact, Importance, Mental health, MBA, GME, BSN, Bangladesh Technical Education Board, Science, Future, National Resident Matching Program, NRMP, National academy, National Academy of Medicine, Physician, Transition, Frank E. Young (physician), Doctor of Health Science, Council, DEI, Growth, Health, Bias, Conference, UME, World Health Organization, Nursing, Student, Match

WASHINGTON, Sept. 11, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) is pleased to announce its national in-person stakeholder conference, Transition to Residency: Conversations Across the Medical Education Continuum, will take place October 5 – 7, 2023, in Boston, MA. The conference provides a unique opportunity for members of the medical education community, including medical schools, residency programs, resident physicians, and medical students, to come together, network, and collaborate on ways to improve the transition to residency and support young physicians.

Key Points: 
  • The conference provides a unique opportunity for members of the medical education community, including medical schools, residency programs, resident physicians, and medical students, to come together, network, and collaborate on ways to improve the transition to residency and support young physicians.
  • "We're looking forward to welcoming residency program and medical school faculty along with learners to Boston this year," said NRMP President and CEO Donna L. Lamb, DHSc, MBA, BSN.
  • "This conference affords the NRMP the opportunity to engage with attendees and consider consequential changes to the transition to residency, what those could mean for learners, and how such changes could improve or impair the transition.
  • This year's conference theme, The Next 70 Years: Our Imperative to Build a Better Transition to Residency, is designed to get attendees thinking about the future of the Match.

Entravision and Match Media Group Partner Across Africa

Retrieved on: 
Friday, September 1, 2023
Technology, Mobile, Wireless, Audio, Video, Social Media, Entertainment, Blogging, General Entertainment, Other Communications, Marketing, Digital Marketing, Advertising, Communications, Internet, Consumer Electronics, Growth, Tinder, Match Group, League, Partnership, EVC, OkCupid, Multimedia, Investment, NYSE, Video game, Entravision Communications, Match

Entravision (NYSE: EVC), a leading global advertising solutions, media and technology company, announced today that its African based digital business unit has become the exclusive sales partner in Africa of Match Media Group, the group that powers advertising for brands including Tinder, OkCupid and Match.

Key Points: 
  • Entravision (NYSE: EVC), a leading global advertising solutions, media and technology company, announced today that its African based digital business unit has become the exclusive sales partner in Africa of Match Media Group, the group that powers advertising for brands including Tinder, OkCupid and Match.
  • Today, hundreds of millions of singles have found a meaningful connection using Match Group services.
  • “This partnership with Match Media Group reinforces our commitment to advertisers to connect brands to consumers through local strategic support, creative expertise and a suite of innovative advertising opportunities on the platform,” said Julian Jordaan, President of Entravision Africa.
  • We’re thrilled to be partnered with Match Media Group in Africa to connect consumers to brands in an authentic and relevant way.”
    As the exclusive sales partner to Match Media Group across the African continent, Entravision has created a dedicated local team of experts based in South Africa to provide businesses with the tools crucial to sales growth, while also assisting customers in deploying their advertising investments more efficiently across their digital technologies.

Ossium Health® and Be The Match® Unveil Partnership to Increase Bone Marrow Transplant Accessibility and Treatment Efficiency

Retrieved on: 
Thursday, August 31, 2023
Stem Cells, Biotechnology, Other Health, Health, General Health, Oncology, Other Science, Research, Surgery, Science, Clinical Trials, National Marrow Donor Program, Partnership, NMDP, Clinical trial, Bone marrow, AP, Multimedia, Cell, Organization, Patient, Transplant, Safety, Dentistry, Match

View the full release here: https://www.businesswire.com/news/home/20230831050319/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230831050319/en/
    Ossium and NMDP/Be The Match are kicking off a clinical trial to demonstrate the safety and efficacy of Ossium’s bone marrow product.
  • PRESERVE I “A First-in-Human Study of HLA-Partially to Fully Matched Allogeneic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies” ( NCT05589896 ) is anticipated to open in Q4 2023.
  • With favorable trial results, the two organizations will then work to integrate the bone marrow donations in Ossium Health's proprietary bank into NMDP/Be The Match's national donor registry.
  • This partnership will dramatically increase Ossium’s ability to serve patients at scale, and allow NMDP/Be The Match to offer a new source of life-saving bone marrow to a wider group of patients in need.